A retrospective analysis of antibiotic prescriptions in England published yesterday in the Journal of Antimicrobial Chemotherapy found that nearly 8% of all antibiotics dispensed in primary care are prescribed by non-medical prescribers (NMPs), mostly nurses.
Canadian researchers are reporting the first case of the drug-resistant fungal pathogen Candida auris in Canada.
A study yesterday in Antimicrobial Resistance and Infection Control found that patients with methicillin-resistant Staphylococcus aureus (MRSA) in Norway have longer hospital stays and incur higher costs than those without MRSA.
The sharp rise is independent of known C diff risk factors and occurred across all US regions.
The study appears to be the first to measure colonization incidence or infections as a primary outcome.
Hospital patients who receive antibiotic treatment may face about a 20% risk of a related adverse event, if the results of a new study from Johns Hopkins University researchers can be generalized.
One study found that antibiotic use was the main factor driving differences.
A study yesterday in BMC Infectious Diseases indicates that piperacillin/tazobactam (PTZ) is effective in treating healthcare-associated urinary tract infection (UTI) caused by extended-spectrum, beta-lactamase-producing Escherichia coli (ESBL-EC), a type of infection for which therapeutic options are limited.
A review of hospital-onset Pseudomonas aeruginosa infections in the United States found that the mortality from multidrug-resistant P aeruginosa (MDR-PSA) is nearly twice that of non-MDR-PSA infections.
Implementation of an antimicrobial stewardship program (ASP) at a rural community hospital in Georgia significantly reduced Clostridium difficile infections (CDIs), antimicrobial use, and overall drug costs, researchers reported yesterday in the American Journal of Infection Control.
